scorecardresearch
Add as a preferred source on Google
Monday, January 5, 2026
TopicHypertension

Topic: hypertension

Experimental drug shows promise in treatment of hard-to-control high blood pressure

AstraZeneca’s experimental drug baxdrostat cut systolic BP by nearly 10 mmHg in a late-stage trial, offering hope to patients at a high risk of heart attacks, among others.

Researchers bat for price cap for hypertension fixed-dose combinations as trial proves efficacy

If included in National List of Essential Medicines (NLEM), the fixed-dose combinations (FDCs) to rein in hypertension can be made available free of cost to patients through government hospitals.

ICMR-NIE launches initiative to tackle poor follow-ups, gaps in diabetes, hypertension treatment

Fewer than 10 percent of people with hypertension had their blood sugar under control & fewer than 66 percent of diabetics had metabolic disorder under control in 2019-21.

Take that salt shaker off the table, say doctors at talk on India’s non-communicable diseases burden

Non-communicable diseases account for over 60% deaths in India, with cardiovascular diseases being the leading cause. The trend is attributed to excessive salt consumption.

Over 40% hospitals below district level lack basic diabetes, hypertension drugs—ICMR-WHO survey of 7 states

Survey also found a shortage of 82.2% physicians and 83.2% surgeons at community health centre-level facilities, considered crucial for providing secondary-level healthcare services. 

Swap table salt with low sodium substitutes, says WHO. Why Indian doctors say this can save lives

According to medical experts, the new guidance is a transformative step toward reducing hypertension & cardiovascular disease globally, including India.

Almost 50% Indian men, 37% women with hypertension don’t have BP in control—analysis of NFHS data

Analysis by researchers associated with institutions including Mumbai's Indian Institute of Population Sciences & Post Graduate Institute of Medical Education and Research, Chandigarh.

Trial in India finds 2-drug combinations 5 times more effective than single pill in controlling hypertension

Amlodipine & perindopril, amlodipine & indapamide, and perindopril & indapamide achieved blood pressure control in 70 percent of patients to less than 140/90 mm Hg in six months.

Yoga, dual therapies — 1st India-specific guidelines for those with both hypertension & diabetes

Key feature of guidelines is emphasis on using multiple methods to measure hypertension, including home BP monitoring. For the first time, yoga is recommended as an adjunct therapy

Hypertension care guidelines miss out on endorsing low-sodium & potassium-enriched salt, says study

In global collaboration, researchers reviewed 32 guidelines, including India’s & published results in journal 'Hypertension', found only China & Europe recommend potassium-enriched salt.

On Camera

US military intervention in Venezuela — the 3 lessons to remember

The US military operation in Venezuela raises global concern. Experts say that Trump’s action could weaken global legal standards and fuel geopolitical instability.

Trump threatens India with fresh tariffs on Russian oil, calls PM Modi a ‘good guy’

The latest comment comes as New Delhi and Washington have yet to sign a trade agreement. India’s purchase of Russian oil has reduced, but Moscow remains top source for crude.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.